JP MORGAN/PUT/BECTON DICKINSON AND CO./210/0.1/17.01.25 Share Price

Warrant

DE000JL1KNC1

Market Closed - Bid/Ask 12:39:08 27/06/2024 pm IST After market 11:45:10 pm
1.13 EUR +4.63% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./210/0.1/17.01.25 1.215 +7.52%
Current month-22.30%
1 month-16.92%
Date Price Change
27/24/27 1.13 +4.63%
26/24/26 1.08 +5.88%
25/24/25 1.02 +4.08%
24/24/24 0.98 -1.01%
21/24/21 0.99 -10.81%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 12:39 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNC
ISINDE000JL1KNC1
Date issued 05/04/2023
Strike 210 $
Maturity 17/01/2025 (204 Days)
Parity 10 : 1
Emission price 1.19
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.51
Lowest since issue 0.9
Delta-0.29x
Omega 5.250
Premium14.36x
Gearing18.16x
Moneyness 0.9115
Difference Strike -19.37 $
Difference Strike %-9.22%
Spread 0.03
Spread %2.50%
Theoretical value 1.185
Implied Volatility 35.32 %
Total Loss Probability 61.90 %
Intrinsic value 0.000000
Present value 1.185
Break even 197.32 €
Theta-0.03x
Vega0.05x
Rho-0.03x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus